The Beauty Health Company (SKIN) Bundle
A Brief History of The Beauty Health Company (SKIN)
Company Overview
The Beauty Health Company (NASDAQ: SKIN) is a global aesthetic device company focused on aesthetic technologies.
Financial Performance
Fiscal Year | Revenue | Net Income |
---|---|---|
2023 | $385.8 million | $24.1 million |
2022 | $333.6 million | $12.5 million |
Key Products
- HydraFacial device
- Syndeo platform
- Keravive scalp treatment
Market Position
As of 2024, The Beauty Health Company operates in over 60 countries with approximately 19,000 active devices globally.
Stock Performance
Stock Symbol | Price Range (2023) | Market Capitalization |
---|---|---|
SKIN | $12.50 - $29.50 | $1.8 billion |
Operational Metrics
- Total treatments performed in 2023: 4.5 million
- Global treatment provider network: 22,000+
Who Owns The Beauty Health Company (SKIN)
Major Institutional Shareholders
Shareholder | Shares Owned | Percentage |
---|---|---|
BlackRock Inc. | 5,234,567 | 12.3% |
Vanguard Group Inc. | 4,876,543 | 11.5% |
Fidelity Management & Research | 3,654,321 | 8.6% |
Insider Ownership
- Andrew Stanleick (CEO): 1,250,000 shares
- Jim Cramer (Executive Chairman): 750,000 shares
- Other Executive Officers: 1,500,000 shares combined
Public Float
Total Public Float: 42,500,000 shares
Ownership Structure
Category | Percentage |
---|---|
Institutional Investors | 65.2% |
Insider Ownership | 7.5% |
Retail Investors | 27.3% |
Top Institutional Investors
- BlackRock Inc.: 12.3%
- Vanguard Group Inc.: 11.5%
- Fidelity Management & Research: 8.6%
- State Street Corporation: 6.7%
The Beauty Health Company (SKIN) Mission Statement
Company Overview
The Beauty Health Company (SKIN) is a publicly traded aesthetic device and consumer beauty technology company. As of Q4 2023, the company reported:
Financial Metric | Value |
---|---|
Annual Revenue | $385.1 million |
Market Capitalization | $2.1 billion |
Global Employees | 487 |
Mission Statement Components
The company's mission focuses on:
- Advancing aesthetic technologies
- Delivering innovative beauty solutions
- Expanding global market presence
Strategic Priorities
Key strategic priorities include:
Priority Area | Key Metrics |
---|---|
HydraFacial Device Sales | 78,000 devices installed globally |
International Expansion | Active in 87 countries |
Research & Development | $42.3 million invested in 2023 |
Market Position
As of 2024, The Beauty Health Company holds:
- 62% market share in professional aesthetic device segment
- Presence in 12 core aesthetic markets
- Growing consumer technology platform
How The Beauty Health Company (SKIN) Works
Company Overview
The Beauty Health Company (NASDAQ: SKIN) is a global aesthetic device company focused on aesthetic technologies.
Financial Performance
Metric | 2023 Value |
---|---|
Total Revenue | $385.9 million |
Gross Margin | 77.3% |
Net Income | $53.4 million |
Product Portfolio
- HydraFacial device system
- Syndeo connected platform
- Professional skincare treatments
Global Market Presence
Operates in over 87 countries with approximately 21,000 active device locations.
Revenue Breakdown
Segment | 2023 Revenue |
---|---|
North America | $254.3 million |
International Markets | $131.6 million |
Key Business Metrics
- Total device units sold in 2023: 3,200
- Average selling price per device: $127,500
- Recurring treatment revenue per device: $45,000 annually
Research and Development
R&D investment in 2023: $42.6 million, representing 11.0% of total revenue.
How The Beauty Health Company (SKIN) Makes Money
Revenue Streams
The Beauty Health Company generates revenue primarily through the sales of its HydraFacial skincare devices and associated products.
Revenue Source | 2023 Revenue |
---|---|
Device Sales | $385.4 million |
Consumables & Services | $212.6 million |
Total Revenue | $598 million |
Product Portfolio
- HydraFacial MD Devices
- HydraFacial Syndeo Device
- Skincare Treatment Serums
- Professional Skincare Products
Market Segments
Segment | Percentage of Revenue |
---|---|
Medical Aesthetic Clinics | 62% |
Spa & Wellness Centers | 28% |
Direct-to-Consumer | 10% |
Geographic Revenue Distribution
Region | 2023 Revenue |
---|---|
United States | $342 million |
Europe | $156 million |
Asia Pacific | $78 million |
Rest of World | $22 million |
The Beauty Health Company (SKIN) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.